An Open-label Study of Ozanimod in Moderate to Severe Ulcerative Colitis in Clinical Practice

PHASE4TerminatedINTERVENTIONAL
Enrollment

139

Participants

Timeline

Start Date

December 16, 2022

Primary Completion Date

January 21, 2025

Study Completion Date

April 11, 2025

Conditions
Colitis, Ulcerative
Interventions
DRUG

Ozanimod

Specified dose on specified days

Trial Locations (85)

10021

Local Institution - 0176, New York

13502

Local Institution - 0170, Utica

24502

Local Institution - 0197, Lynchburg

33033

Local Institution - 0050, Homestead

34684

Local Institution - 0037, Palm Harbor

40202

Local Institution - 0183, Louisville

53792

University of Wisconsin Hospital and Clinics, Madison

60005

Local Institution - 0198, Arlington Heights

60031

Local Institution - 0098, Gurnee

60611

Local Institution - 0051, Chicago

75246

Local Institution - 0138, Dallas

77024

Ace Clinical Research Group: Digestive Health Associates, Houston

77030

Houston Methodist Hospital, Houston

Local Institution - 0052, Houston

77401

Local Institution - 0038, Bellaire

Novel Research LLC, Bellaire

77494

Local Institution - 0129, Katy

77598

Local Institution - 0091, Webster

95116

Local Institution - 0185, San Jose

36305-1156

Local Institution - 0048, Dothan

85224-1636

Local Institution - 0206, Chandler

85297-0425

Local Institution - 0216, Gilbert

85351-2867

Local Institution - 0125, Sun City

85724-0001

Local Institution - 0195, Tucson

72117-2927

Local Institution - 0045, North Little Rock

92307-1329

Local Institution - 0165, Apple Valley

93012-5156

Local Institution - 0162, Camarillo

93534-5856

Local Institution - 0014, Lancaster

OM Research LLC - Lancaster - ClinEdge - PPDS, Lancaster

90045-3119

Local Institution - 0209, Los Angeles

92103-5639

Local Institution - 0002, San Diego

92123-4207

Local Institution - 0208, San Diego

80120-5641

Local Institution - 0178, Littleton

33756-3839

Gastro Florida, Clearwater

Local Institution - 0018, Clearwater

33064-7058

Local Institution - 0026, Lighthouse PT

33136-1002

Local Institution - 0167, Miami

33016-5861

Local Institution - 0049, Miami Lakes

Wellness Clinical Research-Miami Florida, Miami Lakes

34102-5449

Gastroenterology Group of Naples, Naples

Local Institution - 0003, Naples

32073-4752

Local Institution - 0058, Orange Park

32806-1110

Local Institution - 0205, Orlando

33414-3187

Local Institution - 0179, Wellington

30076-4969

Local Institution - 0027, Roswell

66160-8500

Local Institution - 0192, Kansas City

66606-1539

Local Institution - 0181, Topeka

70809-2440

Local Institution - 0200, Baton Rouge

20815-7313

Local Institution - 0171, Chevy Chase

21061-9121

Local Institution - 0191, Glen Burnie

02111

Local Institution - 0199, Boston

01655

Local Institution - 0196, Worcester

55446-3661

Local Institution - 0174, Plymouth

39564-5803

Local Institution - 0184, Ocean Springs

63005-1248

Local Institution - 0024, Chesterfield

63304-9103

Local Institution - 0213, Weldon Spring

07631-4141

Local Institution - 0180, Englewood

11203-2054

Local Institution - 0084, Brooklyn

10016-6821

Local Institution - 0187, New York

10016-9401

Local Institution - 0059, New York

NYU Langone Health -Inflammatory Bowel Disease Center, New York

27834-3761

Carolina Digestive Diseases, Greenville

45229-3019

Local Institution - 0005, Cincinnati

University of Cincinnati Physicians Company, Cincinnati

43235-5424

Local Institution - 0188, Columbus

44060-6521

Local Institution - 0061, Mentor

02905-3105

Local Institution - 0060, Providence

38018-6362

Local Institution - 0177, Cordova

37211-4981

Local Institution - 0168, Nashville

77024-2469

Local Institution - 0036, Houston

Local Institution - 0163, Houston

79410-2014

Local Institution - 0161, Lubbock

76063-6083

GI Alliance: Mansfield - TDDC, Mansfield

Local Institution - 0039, Mansfield

78229-3270

Local Institution - 0201, San Antonio

78229-4463

Local Institution - 0043, San Antonio

San Antonio Gastroenterology, San Antonio

78666-7502

Local Institution - 0166, San Marcos

75701-4464

Local Institution - 0046, Tyler

Tyler Research Institute, LLC, Tyler

84403-3294

Local Institution - 0193, Ogden

84132-0001

Local Institution - 0169, Salt Lake City

98104-1356

Local Institution - 0130, Seattle

98405-2318

Local Institution - 0189, Tacoma

53705-1311

Local Institution - 0017, Madison

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT05369832 - An Open-label Study of Ozanimod in Moderate to Severe Ulcerative Colitis in Clinical Practice | Biotech Hunter | Biotech Hunter